University of Chicago Medical Center
Chicago, Illinois, 60637, United States
Location status: Recruiting
NCT Number: NCT06436235
This observational study aims to look at the connections between kidney stones, insulin resistance, and inflammation. The researchers hypothesize that people who form calcium kidney stones and have insulin resistance may have higher levels of inflammation because they have more visceral fat (fat around the abdominal organs).
The study will recruit 20 people who have had calcium kidney stones but don't have diabetes, and 20 healthy people who haven't had kidney stones. All the participants will come to the research center at the University of Chicago Medicine. Participants will have a dual-energy X-ray absorptiometry (DEXA) scan to measure their visceral fat, and give blood and urine samples. The blood will be tested for insulin resistance, inflammatory markers, and other metabolic factors. The urine will be analyzed for substances that increase kidney stone risk.
The main goal is to see if the kidney stone formers with insulin resistance have more visceral fat compared to those without insulin resistance and the healthy participants. The researchers will also compare inflammatory marker levels between groups, and look at how visceral fat, inflammatory markers, insulin resistance, and urine stone risk factors are related.
The findings may help explain how kidney stones are connected to metabolic conditions like diabetes and cardiovascular disease. Researchers hope this information will help identify stone formers at risk early and develop preventive treatments in the future.
Interested in participating?
Request Info18 year–70 year
All sexes
Observational
Chicago, Illinois, 60637, United States
Location status: Recruiting
Participants will be recruited from the University of Chicago Medicine Kidney Stone Clinic (stone formers) and research participant registries (controls). After providing informed consent, participants will complete the following procedures:
Pre-Study:
Study Visit:
Sample Analysis:
Urine:
1.24-hour and timed urine samples will be analyzed for kidney stone risk chemistries including volume, pH, solutes (calcium, oxalate, uric acid, citrate, etc).
Blood:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
(for both groups):
Time frame: 1 week total, one half day in the CRC
Levels of visceral fat as measured by dual x-ray absorptiometry (DEXA).
Time frame: 1 week total, one half day in the CRC
Markers of systemic inflammation, including high-sensitivity CRP, interleukin-6, MMP-7, MMP-9, TNF-alpha, and endotrophin.
Time frame: 1 week total, one half day in the CRC
Correlation between visceral fat levels (measured by dual x-ray absorptiometry [DEXA]) and the following markers of systemic inflammation:
Time frame: 1 week total, one half day in the CRC
Differences in urine composition based on:
Time frame: 1 week total, one half day in the CRC
Differences in visceral fat levels (measured by DEXA) between kidney stone patients and controls
Time frame: Time Frame: 1 week total, one half day in the CRC
Differences in insulin resistance between kidney stone patients and controls, measured by:
Time frame: Time Frame: 1 week total, one half day in the CRC
Differences in markers of systemic inflammation between kidney stone patients and controls, including:
Contact information is provided by the study sponsor or research team.
University of Chicago
Other
Inflammation and Insulin Resistance in Kidney Stone Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07620873
Anxiety Disorders, Calculi
Keelung, Taiwan
View Trial DetailsNCT06653738
Calculi, Dietary Exposure
Amiens, France
View Trial DetailsNCT05993546
Calculi, Female Urogenital Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT06330246
Calculi, Female Urogenital Diseases
Birmingham, Alabama, United States
View Trial Details